Early antiretroviral therapy and mortality among HIV-infected infants - Wikidata - awgldk - TriplyDB

Early antiretroviral therapy and mortality among HIV-infected infants

Early antiretroviral therapy and mortality among HIV-infected infants

http://www.wikidata.org/entity/Q34175450

about

Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda HIV testing for children in resource-limited settings: what are we waiting for?Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old Optimal time for initiating antiretroviral therapy (ART) in HIV-positive, treatment-naive children aged 24 to 59 months (2 to 5 years old)Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age A paper and plastic device for performing recombinase polymerase amplification of HIV DNA Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification The Diagnosis of HIV Infection in Infants and Children Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition Model HIV and tuberculosis--science and implementation to turn the tide and reduce deaths A lifecycle approach to HIV prevention in African women and children Male involvement for the prevention of mother-to-child HIV transmission: A brief review of initiatives in East, West, and Central Africa Lung function abnormalities in HIV-infected adults and children Treatment of young children with HIV infection: using evidence to inform policymakers Host factors and early treatments to restrict paediatric HIV infection and early disease progression Mother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuum Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth The challenge of chronic lung disease in HIV-infected children and adolescents HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study Asking the right questions: developing evidence-based strategies for treating HIV in women and children The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.Getting to 90-90-90 in paediatric HIV: What is needed?Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions Paediatric HIV management at primary care level: an evaluation of the integrated management of childhood illness (IMCI) guidelines for HIV.Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study.A 10-year cohort analysis of routine paediatric ART data in a rural South African setting.

P2860

Q21034187-AD4382EE-F599-4711-8FA0-4E7B536A1FBE Q21144628-7DECDC6E-2A53-4B42-96BB-525DB9115296 Q24194589-95E832A9-6544-459E-AA5E-ABFEBA7E2E2E Q24197527-E7E468DF-7E8A-450B-99F9-943851EC1524 Q24200412-46132422-6415-4AD0-9124-AD24E7020BC3 Q24202004-2835C873-7BAB-4228-B841-FABDCA553190 Q24623142-7B31EBB9-78F7-4F8F-BA36-CEBD14B1DE2E Q24634551-F7369E78-85F9-45A9-957A-0619721B1FB1 Q26738645-9282DFC5-7D71-4AFC-B915-895F80034E65 Q26765043-59673A46-D1C4-4959-8AE6-FCBDCE8F1F2C Q26774267-FA139688-2C55-4F26-8817-9E7D3E2998CB Q26778483-B9AA80C9-35B3-4027-B4CF-2788D0416DDF Q26824501-83DCB445-C70A-4B8B-9F08-78F04FE9D61C Q26829308-C308F1FC-7B72-48F3-A570-594A79EC6140 Q26853105-9B0D23B8-164C-4E1B-A61D-0D3A461FA608 Q26863389-ACF30E86-BFFB-40E2-BBFB-73A128C9DE46 Q26864053-BE4FAE97-44F1-4CA8-9A9C-7B84A8189D00 Q28082411-D917B4E8-0403-46DA-B5C6-6BF7A69680A2 Q28082436-78234FD4-6C7E-4CAB-BFDF-B5D24A40D8A4 Q28365388-0740300A-80B2-4A4E-8BD7-07D3EC4852C1 Q28384616-E5846BFC-35BA-4EB8-A8D8-E60F876CC8E4 Q28473637-AF348FAD-BBCE-466A-837E-3FC61058B5F1 Q28477542-18B429A2-73E3-4E1C-BC19-309208A65F38 Q28477926-5DB26F84-375E-4267-A310-C7303701FB0E Q28483967-BD1008F6-145A-4346-B859-0F40D38D431D Q28535251-FD94E7B2-8168-457C-8299-B72D165AEC7A Q28535891-0812E88E-62D7-4A77-BA98-7BE2C8C74D65 Q28538692-7E504999-5ADA-4403-9784-0CF72B611C9D Q28546698-B7585131-A17F-4FEF-8B76-AD97834726BE Q28554853-264917F1-8DA7-4335-8455-15749F8EC8CE Q28608305-DD52B821-A972-4B3A-9ED8-AF62A502242D Q28731424-EC599921-A98D-4443-B666-AFED2A548989 Q28743488-F546854F-7855-4A57-83E3-001CA7173CB3 Q30382184-F8EAE938-DDD2-460B-97AD-C96DAD9655AA Q30385352-0915D835-41ED-4C57-9B98-B2020B8ECF94 Q30494934-DCFDD043-9191-4D39-A04A-5E148F3BAD32 Q30495089-F3DFC902-97E5-439D-BCE3-9A03B85CF5FB Q30873977-150D6EB9-9C93-4DB1-AA0B-0DC575888B86 Q31039733-3B1436A2-186C-4236-A034-838F9E66EF6F Q31127942-0C26E8F7-E618-43B5-A279-748BDCCD2FE8

P2860

Early antiretroviral therapy and mortality among HIV-infected infants

http://www.wikidata.org/entity/Q34175450

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Early antiretroviral therapy and mortality among HIV-infected infants

@ast

Early antiretroviral therapy and mortality among HIV-infected infants

@en

Early antiretroviral therapy and mortality among HIV-infected infants

@nl

type

label

Early antiretroviral therapy and mortality among HIV-infected infants

@ast

Early antiretroviral therapy and mortality among HIV-infected infants

@en

Early antiretroviral therapy and mortality among HIV-infected infants

@nl

prefLabel

Early antiretroviral therapy and mortality among HIV-infected infants

@ast

Early antiretroviral therapy and mortality among HIV-infected infants

@en

Early antiretroviral therapy and mortality among HIV-infected infants

@nl

P1433

Q34175450-5984E814-26BB-4B77-B185-0533C845234A

P1476

Q34175450-39846044-72A9-4273-BC4E-F9BDF12B762E

P2093

Q34175450-52E03C59-4BB2-4E89-AA59-5D85F7AE285C

Q34175450-6AC32EC7-C828-4EF6-83E2-7C8A441411DF

Q34175450-701978D5-48BC-471F-A01C-F6DE2C6DD6B3

Q34175450-81F53FF9-94E2-4D3B-AED9-672D82083B8D

Q34175450-8EE166A7-3EDE-4CB9-BA8A-090D229AD280

Q34175450-C1F51B99-7930-4F0F-B6C6-19FBC393360B

Q34175450-C2EDD995-17BB-4907-B025-E7C6E76F8C51

Q34175450-E080E976-1D25-4D0E-A5DD-50DAD18A8B53

P2860

Q34175450-01CF0782-D6E9-4965-B2C6-DD0F6ABD229D

Q34175450-0A94CD49-F290-4F8E-85A4-8B842BA196BA

Q34175450-0AC991E9-523C-4B8F-9F0D-C3B4B5C40945

Q34175450-18B0F744-D8F9-4191-B02F-E8437C9D7910

Q34175450-1D7C3F5C-D9E1-44A5-B302-09D07F8E8265

Q34175450-3038A224-CD1C-406B-A7B8-420BF7803E20

Q34175450-3BD0A0FF-1037-4D94-80A2-05588C8B7EC4

Q34175450-47397869-221F-4FE8-A61F-8F9B3698BF01

Q34175450-5AAB9288-545D-4124-A9E4-7B4699ADC4A5

Q34175450-5E9E9021-9579-4754-A902-578D67012BE0

P304

Q34175450-301C5C60-83F2-454C-AC4A-8D0499887CDB

P31

Q34175450-B2BFC306-9170-4511-A61B-ADBD63A5D47E

P356

Q34175450-37099F7E-094F-4A88-B711-AAF3796DC73D

P407

Q34175450-39E4ADDB-63BF-4F3E-8629-3798D1812537

P433

Q34175450-F9C213E5-CC71-4286-833F-7E55AA4D745A

P478

Q34175450-ED3CECAC-22E1-433F-937E-3365AF07F600

P50

Q34175450-BF0812E1-DFF5-43DB-9E1C-84FFD7091ECF

P577

Q34175450-C39D0FFF-D7E1-4264-ADC9-10AC1A9DDA21

P698

Q34175450-498697C9-6023-4337-B926-2F50BDFE01A5

P921

Q34175450-A2002A3F-0303-4EE2-A742-A0BB8868D6B9

Q34175450-C37992AB-89AD-41DD-9EF1-3A2847B59AF3

P932

Q34175450-22496D72-F654-4F4D-AD5E-443237F042D0

P356

P1433

The New England Journal of Medicine

P1476

Early antiretroviral therapy and mortality among HIV-infected infants

@en

P2093

Abdel G Babiker

http://www.w3.org/2001/XMLSchema#string

Avy Violari

http://www.w3.org/2001/XMLSchema#string

CHER Study Team

http://www.w3.org/2001/XMLSchema#string

Diana M Gibb

http://www.w3.org/2001/XMLSchema#string

James A McIntyre

http://www.w3.org/2001/XMLSchema#string

Jan Steyn

http://www.w3.org/2001/XMLSchema#string

Mark F Cotton

http://www.w3.org/2001/XMLSchema#string

Patrick Jean-Philippe

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children.

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

A trial of three antiretroviral regimens in HIV-1-infected children.

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial.

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.

PENTA guidelines for the use of antiretroviral therapy, 2004.

Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods.

High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.

P304

2233-2244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0800971

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P50

Shabir A. Madhi

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19020325

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

child mortality

P932

2950021

http://www.w3.org/2001/XMLSchema#string